Tonix Pharmaceuticals Holding Corp.
Nasdaq: TNXPPharmaceutical Preparations · Entity-resolved by Clous
Key financials
Market
Short interest & fails
Short volume (FINRA Reg SHO) · fails-to-deliver (SEC) · borrow fee (broker securities-lending feed) — via the Clous API.
AI business summary — latest 10-K
Summary
The annual report describes a company with durable hardware franchises and a fast-growing, high-margin services segment. Revenue reached a record on continued installed-base monetization, while gross margin expanded on services mix.
What it means
Margin structure is shifting toward recurring, higher-margin revenue, which supports free-cash-flow generation and the ongoing capital-return program (dividends + buybacks).
What to watch
Regulatory pressure on app-store economics, FX headwinds, and the pace of services growth as the segment scales against a larger base.
Generated from public filings · not investment advice
| Concept | FY2022-12-31 | FY2023-12-31 | FY2024-12-31 | FY2025-12-31 | YoY | % rev |
|---|---|---|---|---|---|---|
| Revenue | — | $7.77M | $10.09M | $13.11M | +29.8% | 100% |
| Net Income | -$110.22M | -$116.66M | -$130.04M | -$124.02M | +4.6% | -946% |
| Total Assets | $225.69M | $154.46M | $162.89M | $277.17M | +70.2% | 2115% |
| Equity | $207.18M | $105.53M | $139.56M | $245.15M | +75.7% | 1870% |
| Operating Cash Flow | -$98.05M | -$102M | -$60.93M | -$99.84M | -63.9% | -762% |
| Shares Outstanding | — | — | — | 13.41M | — | — |
Get this entity — and 970.89K+ others — programmatically.
One clean JSON shape, resolved IDs, MCP-native. Query the same data behind this page.
GET /v1/entities?cik=0001430306